GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cathay Biotech Inc (SHSE:688065) » Definitions » EV-to-EBIT

Cathay Biotech (SHSE:688065) EV-to-EBIT : 47.13 (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cathay Biotech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cathay Biotech's Enterprise Value is ¥22,399 Mil. Cathay Biotech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ¥475 Mil. Therefore, Cathay Biotech's EV-to-EBIT for today is 47.13.

The historical rank and industry rank for Cathay Biotech's EV-to-EBIT or its related term are showing as below:

SHSE:688065' s EV-to-EBIT Range Over the Past 10 Years
Min: 38.61   Med: 56.87   Max: 179.15
Current: 48.22

During the past 8 years, the highest EV-to-EBIT of Cathay Biotech was 179.15. The lowest was 38.61. And the median was 56.87.

SHSE:688065's EV-to-EBIT is ranked worse than
82.43% of 1212 companies
in the Chemicals industry
Industry Median: 18.94 vs SHSE:688065: 48.22

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cathay Biotech's Enterprise Value for the quarter that ended in Sep. 2024 was ¥27,997 Mil. Cathay Biotech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ¥475 Mil. Cathay Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 1.70%.


Cathay Biotech EV-to-EBIT Historical Data

The historical data trend for Cathay Biotech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cathay Biotech EV-to-EBIT Chart

Cathay Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - 56.23 97.10 48.42 66.66

Cathay Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.10 66.66 49.22 57.43 58.90

Competitive Comparison of Cathay Biotech's EV-to-EBIT

For the Chemicals subindustry, Cathay Biotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cathay Biotech's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cathay Biotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cathay Biotech's EV-to-EBIT falls into.



Cathay Biotech EV-to-EBIT Calculation

Cathay Biotech's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=22399.077/475.302
=47.13

Cathay Biotech's current Enterprise Value is ¥22,399 Mil.
Cathay Biotech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥475 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cathay Biotech  (SHSE:688065) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cathay Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) =EBIT / Enterprise Value (Q: Sep. 2024 )
=475.302/27996.65512
=1.70 %

Cathay Biotech's Enterprise Value for the quarter that ended in Sep. 2024 was ¥27,997 Mil.
Cathay Biotech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥475 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cathay Biotech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cathay Biotech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cathay Biotech Business Description

Traded in Other Exchanges
N/A
Address
1690 Cailun Road, 4th Floor, Building 5, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Cathay Biotech Inc is engaged in Research, development, production and sales of new bio-based materials.

Cathay Biotech Headlines

No Headlines